• 182
  • 25
  • Favorite

Pfizer Stock Slipped 1.53% after Posting Financial Results

Tiger Newspress2022-05-03

Pfizer stock slipped 1.53% after posting financial results.

Pfizer Q1 Non-GAAP EPS of $1.62 beats by $0.05.

Revenue of $25.7B (+77.0% Y/Y) beats by $970M.

Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty and Paxlovid, Revenues Increased 2% Operationally

Reaffirms Full-Year 2022 Financial Guidance(4) for Revenues of $98.0 to $102.0 Billion vs. $105.9B consensus, Which Includes Operational Increases Offset by Approximately $2 Billion of Negative Foreign Exchange Impacts

Reaffirms 2022 Revenue Guidance for Comirnaty of Approximately $32 Billion, Despite a ~$1 Billion Unfavorable Impact from Foreign Exchange

Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a ~$0.5 Billion Unfavorable Impact from Foreign Exchange

Full-Year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45 vs. $7.13 consensus Solely to Reflect an $0.11 Negative Impact for an Accounting Policy Change to Include All Acquired In-Process R&D Expenses in Adjusted Results

Operational Increases Offset the Additional Negative Impact of $0.11 Due to Unfavorable Foreign Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment25

  • Calvin_GKH
    ·2022-05-04
    Omg
    Reply
    Report
  • KCtan1688
    ·2022-05-04
    Like
    Reply
    Report
  • Remotecam
    ·2022-05-03
    $Pfizer(PFE)$stock downtrend, driven only by market makers sentiment that the covid pandamic record earnings is over and it's time to leave.  Outflow would have been worse if they missed estimates.
    Reply
    Report
  • WJ77
    ·2022-05-03
    🤔🤔
    Reply
    Report
  • JarenSin
    ·2022-05-03
    It will still go up nevertheless.
    Reply
    Report
  • KPTan
    ·2022-05-03
    Tq for sharing
    Reply
    Report
  • jilimi
    ·2022-05-03
    👍
    Reply
    Report
  • JohnL
    ·2022-05-03
    Yo
    Reply
    Report
  • SC2021
    ·2022-05-03
    Soar
    Reply
    Report
  • Ahleepapa
    ·2022-05-03
    THE BIG SHORT🤡
    Reply
    Report
  • Trijordan
    ·2022-05-03
    Sad
    Reply
    Report
  • patuick
    ·2022-05-03
    Sigh... When not loved by market, even when profitable, company will be "punished".
    Reply
    Report
  • james_l
    ·2022-05-03
    Might be a buying opportunity
    Reply
    Report
  • phibilim
    ·2022-05-03
    Oh no
    Reply
    Report
  • hynne
    ·2022-05-03
    like
    Reply
    Report
  • IN76
    ·2022-05-03
    Looks like if the company posted strong financialresults, their share price will take a dip. Maybe it is the wrong timing. 
    Reply
    Report
  • Mr Mooney
    ·2022-05-03
    Why slip? Earning is good.right?
    Reply
    Report
  • DenToh
    ·2022-05-03
    Like
    Reply
    Report
  • redmondboy
    ·2022-05-03
    Oh no
    Reply
    Report
  • blessed_1
    ·2022-05-03
    ok
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial